Abstract 4618: Integrative molecular classification of extrahepatic cholangiocarcinoma
Robert Montal(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), T. Pawlik(The Ohio State University Wexner Medical Center), Daniela Sia(Icahn School of Medicine at Mount Sinai), Maria Isabel Fiel(Icahn School of Medicine at Mount Sinai), Parissa Tabrizian(Mount Sinai Hospital), Laia Cabellos(Icahn School of Medicine at Mount Sinai), Lewis R. Roberts(Mayo Clinic), Roser Pinyol(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Beatriz Mínguez, Judit Peix, Christine Sempoux, Augusto Villanueva(NYU Langone Health), Ismaïl Labgaa(University Hospital of Lausanne), Carlos Villacorta(Tisch Hospital), Wei Qiang Leow(SingHealth), Myron Schwartz(Mount Sinai Medical Center), Laia Bassaganyas(Universitat Pompeu Fabra), Swan N. Thung(Icahn School of Medicine at Mount Sinai), Manel Solé(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Miho Maeda, Carla Montironi(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Sasan Roayaie(White Plains Hospital), Agrin Moeini(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas)
Cited by 0
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k